U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C20H31NO2S.ClH
Molecular Weight 385.992
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CETIEDIL HYDROCHLORIDE

SMILES

Cl.O=C(OCCN1CCCCCC1)C(C2CCCCC2)C3=CSC=C3

InChI

InChIKey=ASHVUIMZSYNBHE-UHFFFAOYSA-N
InChI=1S/C20H31NO2S.ClH/c22-20(23-14-13-21-11-6-1-2-7-12-21)19(18-10-15-24-16-18)17-8-4-3-5-9-17;/h10,15-17,19H,1-9,11-14H2;1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C20H31NO2S
Molecular Weight 349.531
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Cetiedil is effective potassium channel blocker used as a peripheral vasodilator to treat patients with painful crises in sickle cell anemia and pain in the extremities caused by an arterial disease. Known pharmacological properties of the drug include vascular smooth muscle relaxation, inhibition of phosphodiesterase with the consequent increase in circulating cyclic AMP concentration, blockade of the effect of bradykinin and serotonin, analgesia, inhibition of platelet aggregation and the decrease of plasma and blood viscosity and plasma fibrinogen level. The antisickling effect of cetiedil is explained mainly in the light of the changes it induces in the activities of membrane-bound ATPases and the permeability properties of the erythrocyte membrane to cations and anions.

Approval Year

PubMed

PubMed

TitleDatePubMed
Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes.
2001 Sep 27
An analysis of the mechanism by which cetiedil inhibits sickling.
2002 Jan 18
Inhibition of the antigen-induced activation of RBL-2H3 cells by cetiedil and some of its analogues.
2004 Jan 12
Inhibition of the antigen-induced activation of RBL-2H3 cells by charybdotoxin and cetiedil.
2004 Jan 12
Pharmacology of the human red cell voltage-dependent cation channel; Part I. Activation by clotrimazole and analogues.
2004 May-Jun
Substance Class Chemical
Created
by admin
on Sat Dec 16 02:17:39 GMT 2023
Edited
by admin
on Sat Dec 16 02:17:39 GMT 2023
Record UNII
WO2TST3H3N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CETIEDIL HYDROCHLORIDE
Common Name English
3-THIOPHENEACETIC ACID, .ALPHA.-CYCLOHEXYL-, 2-(HEXAHYDRO-1H-AZEPIN-1-YL)ETHYL ESTER, HYDROCHLORIDE (1:1)
Systematic Name English
CETIEDIL HYDROCHLORIDE (MI)
Common Name English
Code System Code Type Description
PUBCHEM
118984386
Created by admin on Sat Dec 16 02:17:40 GMT 2023 , Edited by admin on Sat Dec 16 02:17:40 GMT 2023
PRIMARY
CAS
16199-90-9
Created by admin on Sat Dec 16 02:17:40 GMT 2023 , Edited by admin on Sat Dec 16 02:17:40 GMT 2023
PRIMARY
ECHA (EC/EINECS)
240-329-9
Created by admin on Sat Dec 16 02:17:40 GMT 2023 , Edited by admin on Sat Dec 16 02:17:40 GMT 2023
PRIMARY
EPA CompTox
DTXSID90936622
Created by admin on Sat Dec 16 02:17:40 GMT 2023 , Edited by admin on Sat Dec 16 02:17:40 GMT 2023
PRIMARY
FDA UNII
WO2TST3H3N
Created by admin on Sat Dec 16 02:17:40 GMT 2023 , Edited by admin on Sat Dec 16 02:17:40 GMT 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY